ERBB2 and breast cancer: In fact, HER2 overexpression is present in approximately 20% of patients with BC [19], and it is usually associated with more aggressive behavior [20], a higher risk of disease recurrence, and a shorter OS [20,21,22] in comparison to HER2-negative (HER2-) BCs.